Colgate-Palmolive (NYSE:CL) Shares Sold by Sompo Asset Management Co. Ltd.

Sompo Asset Management Co. Ltd. lowered its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 12.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,007 shares of the company's stock after selling 7,400 shares during the period. Colgate-Palmolive accounts for 0.9% of Sompo Asset Management Co. Ltd.'s investment portfolio, making the stock its 29th largest holding. Sompo Asset Management Co. Ltd.'s holdings in Colgate-Palmolive were worth $5,144,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. E Fund Management Hong Kong Co. Ltd. purchased a new stake in shares of Colgate-Palmolive during the second quarter worth approximately $25,000. Core Wealth Advisors Inc. lifted its stake in shares of Colgate-Palmolive by 56.6% in the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company's stock worth $32,000 after acquiring an additional 146 shares during the period. Rise Advisors LLC purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $38,000. Continuum Advisory LLC increased its stake in shares of Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after acquiring an additional 125 shares during the period. Finally, Voisard Asset Management Group Inc. acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth about $40,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. UBS Group lifted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. Citigroup upped their price objective on Colgate-Palmolive from $103.00 to $112.00 and gave the stock a "buy" rating in a report on Wednesday, July 10th. Barclays raised their target price on Colgate-Palmolive from $91.00 to $96.00 and gave the company an "equal weight" rating in a report on Monday, July 29th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. Finally, Sanford C. Bernstein raised their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a research note on Tuesday, July 30th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of "Moderate Buy" and a consensus target price of $102.79.

Colgate-Palmolive Trading Up 1.0 %

Shares of NYSE:CL traded up $1.05 during trading on Friday, reaching $103.06. The stock had a trading volume of 10,926,681 shares, compared to its average volume of 4,358,494. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30. The business has a fifty day moving average price of $102.71 and a 200-day moving average price of $95.83. The stock has a market cap of $84.55 billion, a P/E ratio of 32.61, a PEG ratio of 3.72 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. The company had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. Colgate-Palmolive's revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 EPS. As a group, analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.94%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive's dividend payout ratio (DPR) is 63.29%.

Insider Activity

In related news, insider Sally Massey sold 15,850 shares of the business's stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sally Massey sold 15,850 shares of the business's stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company's stock, valued at approximately $1,439,929.76. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock valued at $4,486,063 in the last 90 days. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.